{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:22:44Z","timestamp":1778595764598,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010793","name":"Pfizer Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP 19fk0108049"],"award-info":[{"award-number":["JP 19fk0108049"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002975","name":"Dainippon Sumitomo Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jiac.2019.10.021","type":"journal-article","created":{"date-parts":[[2019,12,8]],"date-time":"2019-12-08T23:58:08Z","timestamp":1575849488000},"page":"305-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fatal fulminant Clostridioides difficile colitis caused by Helicobacter pylori eradication therapy; a case report"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5387-4973","authenticated-orcid":false,"given":"Takahito","family":"Nei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Yokobori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Shiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Senoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haru","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jiac.2019.10.021_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jiac.2019.10.021_bib2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gutjnl-2017-314205","article-title":"Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota","volume":"67","author":"Ferreira","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jiac.2019.10.021_bib3","article-title":"Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people","volume":"4","author":"Ford","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"10.1016\/j.jiac.2019.10.021_bib4","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1001\/archinte.160.13.1962","article-title":"Impact of Helicobacter pylori infection on gastric cancer incidence in a general Japanese population: the Hisayama study","volume":"160","author":"Yamagata","year":"2000","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.jiac.2019.10.021_bib5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano","year":"2015","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jiac.2019.10.021_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12328-014-0490-6","article-title":"A\u00a0case of severe pseudomembranous colitis diagnosed by colonoscopy after Helicobacter pylori eradication","volume":"7","author":"Sato","year":"2014","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"42","key":"10.1016\/j.jiac.2019.10.021_bib7","doi-asserted-by":"crossref","first-page":"7476","DOI":"10.3748\/wjg.v19.i42.7476","article-title":"Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication","volume":"19","author":"Trifan","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.jiac.2019.10.021_bib8","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1099\/jmm.0.000149","article-title":"Predominance of PCR-ribotypes, 018 (smz) and 369 (trf) of Clostridium difficile in Japan: a potential relationship with other global circulating strains?","volume":"64","author":"Senoh","year":"2015","journal-title":"J\u00a0Med Microbiol"},{"issue":"1","key":"10.1016\/j.jiac.2019.10.021_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2036.1995.tb00350.x","article-title":"Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen","volume":"9","author":"Hudson","year":"1995","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.jiac.2019.10.021_bib10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1046\/j.1365-2036.2001.01033.x","article-title":"Influence of anti-Helicobacter triple-therapy with metronidazole, omeprazole and clarithromycin on intestinal microflora","volume":"15","author":"B\u00fchling","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"issue":"9491","key":"10.1016\/j.jiac.2019.10.021_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","article-title":"Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe","volume":"366","author":"Warny","year":"2005","journal-title":"Lancet"},{"issue":"9759","key":"10.1016\/j.jiac.2019.10.021_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0140-6736(10)61266-4","article-title":"Clostridium difficile infection in Europe: a hospital-based survey","volume":"377","author":"Bauer","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2019.10.021_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.anaerobe.2019.03.007","article-title":"Clostridioides (Clostridium) difficile infection burden in Japan: a multicenter prospective study","author":"Kato","year":"2019","journal-title":"Anaerobe"},{"issue":"5","key":"10.1016\/j.jiac.2019.10.021_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10156-010-0066-4","article-title":"A\u00a0retrospective study of the epidemiology of Clostridium difficile infection at a university hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients","volume":"16","author":"Iwashima","year":"2010","journal-title":"J\u00a0Infect Chemother"},{"issue":"2","key":"10.1016\/j.jiac.2019.10.021_bib15","first-page":"115","article-title":"High morbidity and mortality of Clostridium difficile infection and its associations with ribotype 002 in Hong Kong","volume":"73","author":"Wong","year":"2016","journal-title":"J\u00a0Infect"},{"issue":"9","key":"10.1016\/j.jiac.2019.10.021_bib16","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1099\/jmm.0.057968-0","article-title":"Two cases of fulminant colitis due to binary toxin-positive Clostridium difficile that are not PCR ribotype 027 or type 078","volume":"62","author":"Tagashira","year":"2013","journal-title":"J\u00a0Med Microbiol"},{"issue":"7","key":"10.1016\/j.jiac.2019.10.021_bib17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for Healthcare epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2019.10.021_bib18","series-title":"The Japanese clinical practice guidelines for management of Clostridioides (Clostridium) difficile infections. (available only in Japanese) the Japanese association for infectious diseases and Japanese society of chemotherapy","year":"2018"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19303393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X19303393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:55:46Z","timestamp":1778594146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X19303393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1341321X19303393"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2019.10.021","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatal fulminant Clostridioides difficile colitis caused by Helicobacter pylori eradication therapy; a case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2019.10.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}